Patent assignee · KR · COMPANY

ALTEOGEN Inc.

14Patents
14Active
14Granted
47Portfolio score

Filing activity: Apr 22, 2010 → Dec 14, 2021

Most-cited patents

PatentTitleAreaCited byStatus
US9982032B2 Stable liquid formulation of fusion protein with IgG Fc domain Chemistry; Metallurgy 11 Active
US9814782B2 Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same Chemistry; Metallurgy 7 Active
US9474803B2 Composition for stabilizing fusion protein in which protein and FC domain are fused Chemistry; Metallurgy 4 Active
US9012606B2 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same Chemistry; Metallurgy 4 Active
US9051395B2 Alpha-1 antitrypsin variant, preparation method thereof and use thereof Chemistry; Metallurgy 1 Active
US11235065B2 Antibody-drug conjugate comprising modified antibody Chemistry; Metallurgy 1 Active
US9902753B2 Method of purifying a long-acting human growth hormone Chemistry; Metallurgy 0 Active
US12371683B2 Hyaluronidase variants and pharmaceutical composition comprising the same Chemistry; Metallurgy 0 Active
US11981719B2 Growth hormone receptor antagonists and fusion proteins thereof Chemistry; Metallurgy 0 Active
US11866492B2 Antibody specifically binding to FOLR1 and uses thereof Physics 0 Active
US9821059B2 Composition for stabilizing protein and pharmaceutical formulation comprising the same Chemistry; Metallurgy 0 Active
US12090210B2 Antibody-drug conjugate comprising modified antibody Chemistry; Metallurgy 0 Active
US12221638B2 Method for producing recombinant hyaluronidase Chemistry; Metallurgy 0 Active
US11414476B2 Method for producing fusion protein having IgG Fc domain Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.